Allogene Therapeutics News

Allogene Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

16:13 ET

Allogene Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Chang David D

Mar 18 20:16 ET

Allogene Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 14 17:31 ET

Allogene Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Mar 14 17:25 ET

Allogene Therapeutics | 10-K: Annual report

Mar 14 17:00 ET

Allogene Therapeutics | POSASR: Post-effective amendment to an automatic shelf registration statement on Form S-3ASR or Form F-3ASR

Mar 14 16:56 ET

Allogene Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 14 16:39 ET

Allogene Therapeutics | 8-K: Allogene Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update

Mar 14 16:17 ET

Allogene Therapeutics | 10-K/A: Annual report (Amendment)

Mar 14 16:07 ET

Allogene Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Parker Geoffrey M.

Mar 6 21:55 ET

Allogene Therapeutics | UPLOAD: Others

Feb 29 14:28 ET

Allogene Therapeutics | CORRESP: CORRESP

Feb 22 14:28 ET

Allogene Therapeutics | 8-K: Current report

Feb 16 08:31 ET

Allogene Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Arie Belldegrun, M.D.(5.8%),Bellco Legacy IV, LLC(2.8%), etc.

Feb 14 17:33 ET

Allogene Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-David Chang, M.D., Ph.D.(5.8%),Chang 2006 Family Trust(0.7%), etc.

Feb 14 16:39 ET

Allogene Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(5.37%)

Feb 13 17:09 ET

Allogene Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(14.999%),Abigail P. Johnson(14.999%)

Feb 9 08:40 ET

Allogene Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer MOORE TIMOTHY L.

Jan 31 17:58 ET

Allogene Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Douglas Earl Martin

Jan 31 17:58 ET

Allogene Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Parker Geoffrey M.

Jan 31 17:54 ET